Skip to main content

Aguilar Richard

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Aguilar Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 30, 2023 (view filing)Jun 28-292 daysAguilar RichardChief Clinical OfficerSSaleClass A Common Stock−550.0K$1.29−$707.0K−31.2%1.21M after2 lots
Jun 13, 2023 (view filing)Jun 7-126 daysLateAguilar RichardChief Clinical OfficerSSaleClass A Common Stock−1.28M$1.36−$1.73M−51.2%1.21M after4 lots
Apr 6, 2023 (view filing)Apr 51 dayAguilar RichardChief Clinical OfficerSSaleClass A Common Stock−9.98M–––5.89M afterDerivative2 lots
Apr 6, 2023 (view filing)Apr 51 dayAguilar RichardChief Clinical OfficerPPurchasePCIH Common Units/Class B Common Stock+4.99M–––4.99M afterDerivative
Sep 14, 2021 (view filing)Aug 3015 daysLateAguilar RichardChief Clinical OfficerPPurchaseClass A Common Stock+49.6K$10.75+$532.7K–675.9K afterDerivative2 lots
Sep 1, 2021 (view filing)Aug 302 daysAguilar RichardChief Clinical OfficerPPurchaseClass A Common Stock+1.75K$11.93+$20.9K+1.4%125.2K after
Aug 31, 2021 (view filing)Aug 25-266 daysLateAguilar RichardChief Clinical OfficerPPurchaseClass A Common Stock+123.4K$11.97+$1.48MNew position123.4K after2 lots
Aug 31, 2021 (view filing)Aug 25-306 daysLateAguilar RichardChief Clinical OfficerPPurchaseClass A Common Stock+1.35M$10.51+$14.2M–651.2K afterDerivative4 lots